Financials
- Market Capitalization 84.19 M
- Employee 9
- Founded 2018
- CEO N/A
- Website www.rallybio.com
- Headquarter Delaware, United States
- FIGI BBG011PFKF54
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.45
ratio cours/chiffre d'affaires
36.01
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4055 | NRXS Neuraxis, Inc. Common Stock | 6.88 USD | -3.64% | -7.28% | -1.15% | +26.70% | 85.20 M USD | ||
| 4057 | ACRV Acrivon Therapeutics, Inc. - Common Stock | 1.98 USD | +1.02% | +9.39% | +27.74% | +48.87% | 84.75 M USD | ||
| 4086 | ENTX Entera Bio Ltd. - Ordinary Shares | 1.64 USD | -1.20% | -4.65% | +31.20% | -7.34% | 80.73 M USD | ||
| 4087 | CSBR Champions Oncology, Inc. - Common Stock | 5.81 USD | -0.17% | +1.40% | -10.48% | -27.83% | 80.68 M USD |